178 related articles for article (PubMed ID: 36016147)
1. In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1-4) Isolated from the Philippines.
Abesamis LMI; Aliping EGA; Armada FKGH; Danao MF; Del Valle PDB; Regencia ZJG; Baja ES; Ligsay AD
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016147
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide analog of in silico-predicted immunogenic epitope unique to dengue virus serotype 2 NS1 antigen specifically binds immunoglobulin G antibodies raised in rabbits.
Guevarra LA; Boado KJO; Ceñidoza FBB; Imbao MRLM; Sia MJG; Dalmacio LMM
Microbiol Immunol; 2020 Feb; 64(2):153-161. PubMed ID: 31710119
[TBL] [Abstract][Full Text] [Related]
3. Computational prediction and analysis of envelop glycoprotein epitopes of DENV-2 and DENV-3 Pakistani isolates: a first step towards Dengue vaccine development.
Amat-ur-Rasool H; Saghir A; Idrees M
PLoS One; 2015; 10(3):e0119854. PubMed ID: 25775090
[TBL] [Abstract][Full Text] [Related]
4. Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design.
Chong LC; Khan AM
BMC Genomics; 2019 Dec; 20(Suppl 9):921. PubMed ID: 31874646
[TBL] [Abstract][Full Text] [Related]
5. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
[TBL] [Abstract][Full Text] [Related]
6. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
[TBL] [Abstract][Full Text] [Related]
7. Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine.
Lim HX; Lim J; Poh CL
Med Microbiol Immunol; 2021 Feb; 210(1):1-11. PubMed ID: 33515283
[TBL] [Abstract][Full Text] [Related]
8. Epitope prediction and designing of receptor inhibitor of Dengue Envelope Protein: An
Uttam G; Kumari A; Singh K
J Vector Borne Dis; 2023; 60(2):161-171. PubMed ID: 37417165
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.
Andrade DV; Katzelnick LC; Widman DG; Balmaseda A; de Silva AM; Baric RS; Harris E
mBio; 2017 Sep; 8(5):. PubMed ID: 28928210
[TBL] [Abstract][Full Text] [Related]
10. In silico prediction of monovalent and chimeric tetravalent vaccines for prevention and treatment of dengue fever.
Subramaniyan V; Venkatachalam R; Srinivasan P; Palani M
J Biomed Res; 2017 Nov; 32(3):222-36. PubMed ID: 29497025
[TBL] [Abstract][Full Text] [Related]
11. Natural antibody responses to the capsid protein in sera of Dengue infected patients from Sri Lanka.
Nadugala MN; Jeewandara C; Malavige GN; Premaratne PH; Goonasekara CL
PLoS One; 2017; 12(6):e0178009. PubMed ID: 28582388
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus.
Song KY; Zhao H; Li SH; Li XF; Deng YQ; Wang HJ; Ye Q; Zhu SY; Jiang ZY; Zhang FC; Qin ED; Qin CF
J Gen Virol; 2013 Jul; 94(Pt 7):1510-1516. PubMed ID: 23559476
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.
Crill WD; Hughes HR; Delorey MJ; Chang GJ
PLoS One; 2009; 4(4):e4991. PubMed ID: 19337372
[TBL] [Abstract][Full Text] [Related]
14. Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.
Ahmed SF; Quadeer AA; Barton JP; McKay MR
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008676. PubMed ID: 32956362
[TBL] [Abstract][Full Text] [Related]
15. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
[TBL] [Abstract][Full Text] [Related]
16. Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3).
da Silva AN; Nascimento EJ; Cordeiro MT; Gil LH; Abath FG; Montenegro SM; Marques ET
PLoS One; 2009 Oct; 4(10):e7425. PubMed ID: 19826631
[TBL] [Abstract][Full Text] [Related]
17. Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine.
Lin TH; Chen HW; Hsiao YJ; Yan JY; Chiang CY; Chen MY; Hu HM; Wu SH; Pan CH
Front Immunol; 2020; 11():546. PubMed ID: 32300346
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics Aided Design and
Kaushik V; G SK; Gupta LR; Kalra U; Shaikh AR; Cavallo L; Chawla M
Front Immunol; 2022; 13():865180. PubMed ID: 35799781
[No Abstract] [Full Text] [Related]
19. Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes.
Lecouturier V; Berry C; Saulnier A; Naville S; Manin C; Girerd-Chambaz Y; Crowe JE; Jackson N; Guy B
Vaccine; 2019 Jul; 37(32):4601-4609. PubMed ID: 29706291
[TBL] [Abstract][Full Text] [Related]
20. Natural immunogenic properties of bioinformatically predicted linear B-cell epitopes of dengue envelope and pre-membrane proteins.
Nadugala MN; Jeewandara C; Jadi RS; Malavige GN; de Silva AM; Premaratne PH; Goonasekara CL
BMC Immunol; 2021 Nov; 22(1):71. PubMed ID: 34732126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
